Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 2
1992 1
1994 3
1998 1
2000 1
2005 2
2006 2
2008 1
2009 1
2010 1
2011 1
2012 2
2013 2
2014 2
2015 5
2016 7
2017 1
2018 5
2019 5
2020 3
2021 5
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Management of pregnant women with antiphospholipid antibodies.
Ruffatti A, Favaro M, Calligaro A, Zambon A, Del Ross T. Ruffatti A, et al. Among authors: del ross t. Expert Rev Clin Immunol. 2019 Apr;15(4):347-358. doi: 10.1080/1744666X.2019.1565995. Epub 2019 Jan 11. Expert Rev Clin Immunol. 2019. PMID: 30616398 Review.
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases.
Alijotas-Reig J, Ferrer-Oliveras R, Ruffatti A, Tincani A, Lefkou E, Bertero MT, Coloma-Bazan E, de Carolis S, Espinosa G, Rovere-Querini P, Kuzenko A, Valverde EE, Robles A, Cervera R, Canti V, Fredi M, Gil-Aguado A, Lundelin K, Llurba E, Melnychuk T, Nalli C, Picardo E, Silvestro E, del Ross T, Farran-Codina I; (EUROAPS Study Group Collaborators). Alijotas-Reig J, et al. Among authors: del ross t. Autoimmun Rev. 2015 May;14(5):387-95. doi: 10.1016/j.autrev.2014.12.010. Epub 2014 Dec 31. Autoimmun Rev. 2015. PMID: 25555817 Review.
The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies.
Ruffatti A, Tonello M, Favaro M, Del Ross T, Calligaro A, Ruffatti AT, Gervasi MT, Hoxha A. Ruffatti A, et al. Among authors: del ross t. Semin Arthritis Rheum. 2021 Feb;51(1):28-35. doi: 10.1016/j.semarthrit.2020.10.001. Epub 2020 Dec 17. Semin Arthritis Rheum. 2021. PMID: 33360227 Review.
Prevalence and adverse consequences of delayed diagnosis and misdiagnosis in thrombotic antiphospholipid syndrome. An observational cohort study and a review of the literature.
Ruffatti A, Tonello M, Calligaro A, Del Ross T, Favaro M, Zen M, Hoxha A, Alaibac M. Ruffatti A, et al. Among authors: del ross t. Clin Rheumatol. 2023 Nov;42(11):3007-3019. doi: 10.1007/s10067-023-06699-1. Epub 2023 Jul 15. Clin Rheumatol. 2023. PMID: 37453028 Free PMC article. Review.
Clinical and laboratory characteristics of isolated lupus anticoagulants.
Mattia E, Tonello M, Del Ross T, Zerbinati P, Campello E, Simioni P, Ruffatti A. Mattia E, et al. Among authors: del ross t. Thromb Res. 2018 May;165:51-53. doi: 10.1016/j.thromres.2018.03.008. Epub 2018 Mar 13. Thromb Res. 2018. PMID: 29567587 No abstract available.
Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide survey.
Pengo V, Del Ross T, Tonello M, Andreoli L, Tincani A, Gresele P, Silvestri E, Simioni P, Campello E, Hoxha A, Falanga A, Ghirarduzzi A, Denas G; COVID-19 APS collaborators. Pengo V, et al. Among authors: del ross t. Rheumatology (Oxford). 2022 Jun 28;61(SI2):SI136-SI142. doi: 10.1093/rheumatology/keac224. Rheumatology (Oxford). 2022. PMID: 35412604 Free PMC article.
55 results